Literature DB >> 33216758

Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets.

Ben Vezina1, Guillaume A Petit1, Jennifer L Martin1,2, Maria A Halili1.   

Abstract

Identification of bacterial virulence factors is critical for understanding disease pathogenesis, drug discovery and vaccine development. In this study we used two approaches to predict virulence factors of Burkholderia pseudomallei, the Gram-negative bacterium that causes melioidosis. B. pseudomallei is naturally antibiotic resistant and there are no clinically available melioidosis vaccines. To identify B. pseudomallei protein targets for drug discovery and vaccine development, we chose to search for substrates of the B. pseudomallei periplasmic disulfide bond forming protein A (DsbA). DsbA introduces disulfide bonds into extra-cytoplasmic proteins and is essential for virulence in many Gram-negative organism, including B. pseudomallei. The first approach to identify B. pseudomallei DsbA virulence factor substrates was a large-scale genomic analysis of 511 unique B. pseudomallei disease-associated strains. This yielded 4,496 core gene products, of which we hypothesise 263 are DsbA substrates. Manual curation and database screening of the 263 mature proteins yielded 81 associated with disease pathogenesis or virulence. These were screened for structural homologues to predict potential B-cell epitopes. In the second approach, we searched the B. pseudomallei genome for homologues of the more than 90 known DsbA substrates in other bacteria. Using this approach, we identified 15 putative B. pseudomallei DsbA virulence factor substrates, with two of these previously identified in the genomic approach, bringing the total number of putative DsbA virulence factor substrates to 94. The two putative B. pseudomallei virulence factors identified by both methods are homologues of PenI family β-lactamase and a molecular chaperone. These two proteins could serve as high priority targets for future B. pseudomallei virulence factor characterization.

Entities:  

Year:  2020        PMID: 33216758      PMCID: PMC7678975          DOI: 10.1371/journal.pone.0241306

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  99 in total

1.  Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease.

Authors:  C Kooi; C R Corbett; P A Sokol
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  DsbA directs efficient expression of outer membrane secretin EscC of the enteropathogenic Escherichia coli type III secretion apparatus.

Authors:  Tsuyoshi Miki; Nobuhiko Okada; Yeongsuk Kim; Akio Abe; Hirofumi Danbara
Journal:  Microb Pathog       Date:  2007-09-20       Impact factor: 3.738

3.  Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance.

Authors:  David A Kennedy; Andrew F Read
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-17       Impact factor: 11.205

Review 4.  Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis.

Authors:  Herbert P Schweizer
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

5.  Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species.

Authors:  Catherine Ong; Chia Huey Ooi; Dongling Wang; Hweeling Chong; Kim Chong Ng; Fiona Rodrigues; May Ann Lee; Patrick Tan
Journal:  Genome Res       Date:  2004-11       Impact factor: 9.043

6.  Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.

Authors:  Oana Ciofu; Niels Bagge; Niels Høiby
Journal:  APMIS       Date:  2002-12       Impact factor: 3.205

7.  Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Marisa L Winkler; Julian A Gatta; Drew A Rholl; Herbert P Schweizer; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

8.  Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.

Authors:  Róisín M McMahon; Philip M Ireland; Derek S Sarovich; Guillaume Petit; Christopher H Jenkins; Mitali Sarkar-Tyson; Bart J Currie; Jennifer L Martin
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

9.  Development of Subunit Vaccines That Provide High-Level Protection and Sterilizing Immunity against Acute Inhalational Melioidosis.

Authors:  Mary N Burtnick; Teresa L Shaffer; Brittany N Ross; Laura A Muruato; Elena Sbrana; David DeShazer; Alfredo G Torres; Paul J Brett
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

10.  A Web Resource for Designing Subunit Vaccine Against Major Pathogenic Species of Bacteria.

Authors:  Gandharva Nagpal; Salman Sadullah Usmani; Gajendra P S Raghava
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

View more
  1 in total

1.  The suppressor of copper sensitivity protein C from Caulobacter crescentus is a trimeric disulfide isomerase that binds copper(I) with subpicomolar affinity.

Authors:  Guillaume A Petit; Yaoqin Hong; Karrera Y Djoko; Andrew E Whitten; Emily J Furlong; Airlie J McCoy; Jacqueline M Gulbis; Makrina Totsika; Jennifer L Martin; Maria A Halili
Journal:  Acta Crystallogr D Struct Biol       Date:  2022-02-21       Impact factor: 7.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.